Selzentry and Tendon rupture - a phase IV clinical study of FDA data


Tendon rupture is reported only by a few people who take Selzentry.

The phase IV clinical study analyzes which people take Selzentry and have Tendon rupture. It is created by eHealthMe based on reports of 644 people who have side effects while taking Selzentry from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

644 people reported to have side effects when taking Selzentry.
Among them, 2 people (0.31%) have Tendon rupture.

What is Selzentry?

Selzentry has active ingredients of maraviroc. It is often used in hiv infection. eHealthMe is studying from 664 Selzentry users for its effectiveness, alternative drugs and more.

What is Tendon rupture?

Tendon rupture (tear of tendon) is found to be associated with 1,596 drugs and 1,034 conditions by eHealthMe.

Number of Selzentry and Tendon rupture reports submitted per year:

Could Selzentry cause Tendon rupture?

Gender of people who have Tendon rupture when taking Selzentry *:

  • female: 0.0 %
  • male: 100 %

Common drugs people take besides Selzentry *:

  1. Ziagen: 2 people, 100.00%
  2. Norvir: 2 people, 100.00%
  3. Biktarvy: 2 people, 100.00%
  4. Calcium: 2 people, 100.00%
  5. Crixivan: 2 people, 100.00%
  6. Descovy: 2 people, 100.00%
  7. Epivir: 2 people, 100.00%
  8. Fuzeon: 2 people, 100.00%
  9. Intelence: 2 people, 100.00%
  10. Invirase: 2 people, 100.00%

Common side effects people have besides Tendon rupture *:

  1. Wrist Fracture: 2 people, 100.00%
  2. Stress And Anxiety: 2 people, 100.00%
  3. Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 2 people, 100.00%
  4. Renal Impairment (severely reduced kidney function): 2 people, 100.00%
  5. Protein Urine Present: 2 people, 100.00%
  6. Pain: 2 people, 100.00%
  7. Osteoporosis (bones weak and more likely to break): 2 people, 100.00%
  8. Hip Fracture: 2 people, 100.00%
  9. Emotional Distress: 2 people, 100.00%
  10. Bone Density Decreased: 2 people, 100.00%

Common conditions people have *:

  1. Viral Infection: 2 people, 100.00%
  2. Stress And Anxiety: 2 people, 100.00%
  3. Quit Smoking: 2 people, 100.00%
  4. Pain: 2 people, 100.00%
  5. Nausea (feeling of having an urge to vomit): 2 people, 100.00%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 100.00%
  7. High Blood Cholesterol: 2 people, 100.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 100.00%
  9. Depression: 2 people, 100.00%
  10. Bone Pain: 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Selzentry and have Tendon rupture?

Check whether Tendon rupture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Tendon rupture and when was it recovered:

Expand to all the drugs that have ingredients of maraviroc:

Alternative drugs to, pros and cons of Selzentry:

Tendon rupture treatments and more:

COVID vaccines that are related to Tendon rupture:

Common drugs associated with Tendon rupture:

All the drugs that are associated with Tendon rupture:

Common conditions associated with Tendon rupture:

All the conditions that are associated with Tendon rupture:

How the study uses the data?

The study uses data from the FDA. It is based on maraviroc (the active ingredients of Selzentry) and Selzentry (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: